191 related articles for article (PubMed ID: 28095814)
1. Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.
Kawai S; Yokota T; Onozawa Y; Hamauchi S; Fukutomi A; Ogawa H; Onoe T; Onitsuka T; Yurikusa T; Todaka A; Tsushima T; Yoshida Y; Kito Y; Mori K; Yasui H
BMC Cancer; 2017 Jan; 17(1):59. PubMed ID: 28095814
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer.
Shirasu H; Yokota T; Hamauchi S; Onozawa Y; Ogawa H; Onoe T; Onitsuka T; Yurikusa T; Mori K; Yasui H
BMC Cancer; 2020 Mar; 20(1):182. PubMed ID: 32131771
[TBL] [Abstract][Full Text] [Related]
3. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer.
Xu B; Boero IJ; Hwang L; Le QT; Moiseenko V; Sanghvi PR; Cohen EE; Mell LK; Murphy JD
Cancer; 2015 Apr; 121(8):1303-11. PubMed ID: 25537836
[TBL] [Abstract][Full Text] [Related]
4. Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: A single-institution retrospective study in Japan.
Sakashita T; Homma A; Hatakeyama H; Furusawa J; Kano S; Mizumachi T; Iizuka S; Onimaru R; Tsuchiya K; Yasuda K; Shirato H; Fukuda S
Acta Otolaryngol; 2015 Aug; 135(8):853-8. PubMed ID: 25814008
[TBL] [Abstract][Full Text] [Related]
5. Low Skeletal Muscle Mass Is a Risk Factor for Aspiration Pneumonia During Chemoradiotherapy.
Endo K; Ueno T; Hirai N; Komori T; Nakanishi Y; Kondo S; Wakisaka N; Yoshizaki T
Laryngoscope; 2021 May; 131(5):E1524-E1529. PubMed ID: 33030229
[TBL] [Abstract][Full Text] [Related]
6. The efficiency and adverse events of radiotherapy with cetuximab for Japanese head and neck cancer patients.
Hirasawa K; Okamoto I; Motohashi R; Sato H; Takase S; Agata A; Takeda A; Tsukahara K
Auris Nasus Larynx; 2017 Dec; 44(6):724-728. PubMed ID: 28237712
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma.
Nishimura G; Taguchi T; Takahashi M; Shiono O; Komatsu M; Sano D; Yabuki K; Arai Y; Takahashi H; Hata M; Oridate N
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1315-9. PubMed ID: 27154176
[TBL] [Abstract][Full Text] [Related]
8. Aspiration pneumonia related deaths in head and neck cancer patients: a retrospective analysis of risk factors from a tertiary care centre in North India.
Madan R; Kairo AK; Sharma A; Roy S; Singh S; Singh L; Kaur J; Mohanti BK; Bhasker S; Upadhyay AD; Rath GK
J Laryngol Otol; 2015 Jul; 129(7):710-4. PubMed ID: 26077504
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of the Risk Factors for Severe Oral Mucositis in Head and Neck Cancer after Chemoradiotherapy with S-1].
Nagatani A; Ogawa Y; Sunaga T; Tomura K; Naito Y; Fujii N; Okabe T; Hashimoto T; Kogo M; Sasaki T
Yakugaku Zasshi; 2017; 137(2):221-225. PubMed ID: 28154335
[TBL] [Abstract][Full Text] [Related]
10. [The Combination of Molecular Targeted Agents with Radiotherapy in Head and Neck Cancer].
Furuta M; Yokota T
Gan To Kagaku Ryoho; 2018 Mar; 45(3):419-423. PubMed ID: 29650896
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients.
Herrera LJ; Correa AM; Vaporciyan AA; Hofstetter WL; Rice DC; Swisher SG; Walsh GL; Roth JA; Mehran RJ
Ann Thorac Surg; 2006 Dec; 82(6):1982-7; discussion 1987-8. PubMed ID: 17126095
[TBL] [Abstract][Full Text] [Related]
12. Nutritional Care in Patients with Head and Neck Cancer during Chemoradiotherapy (CRT) and Bioradiotherapy (BRT) Provides Better Compliance with the Treatment Plan.
Kapała A; Surwiłło-Snarska A; Jodkiewicz M; Kawecki A
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34064057
[TBL] [Abstract][Full Text] [Related]
13. Predictors of aspiration pneumonia following radiotherapy for head and neck cancer.
Purkey MT; Levine MS; Prendes B; Norman MF; Mirza N
Ann Otol Rhinol Laryngol; 2009 Nov; 118(11):811-6. PubMed ID: 19999368
[TBL] [Abstract][Full Text] [Related]
14. Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancer.
Willemsen ACH; Kok A; Baijens LWJ; de Boer JP; de Bree R; Devriese LA; Driessen CML; van Herpen CML; Hoebers FJP; Kaanders JHAM; Karsten RT; van Kuijk SMJ; Lalisang RI; Navran A; Pereboom SR; Schols AMWJ; Terhaard CHJ; Hoeben A
Clin Nutr; 2022 Jan; 41(1):177-185. PubMed ID: 34883306
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with the development of aspiration pneumonia in patients receiving radiotherapy for head and neck cancer: retrospective study.
Kawashita Y; Morimoto S; Tashiro K; Soutome S; Yoshimatsu M; Nakao N; Kurogi T; Saito T; Ukai T; Umeda M
Head Neck; 2020 Sep; 42(9):2571-2580. PubMed ID: 32478453
[TBL] [Abstract][Full Text] [Related]
16. Late toxicity after radical treatment for locally advanced head and neck cancer.
Taberna M; Rullan AJ; Hierro C; Navarro V; Vázquez S; Lozano A; Vilajosana E; Maños M; Marí A; Viñals J; Mesía R
Oral Oncol; 2015 Aug; 51(8):795-9. PubMed ID: 26051499
[TBL] [Abstract][Full Text] [Related]
17. Disease-induced and treatment-induced alterations in body composition in locally advanced head and neck squamous cell carcinoma.
Willemsen ACH; Hoeben A; Lalisang RI; Van Helvoort A; Wesseling FWR; Hoebers F; Baijens LWJ; Schols AMWJ
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):145-159. PubMed ID: 31536685
[TBL] [Abstract][Full Text] [Related]
18. Prediction model for tube feeding dependency during chemoradiotherapy for at least four weeks in head and neck cancer patients: A tool for prophylactic gastrostomy decision making.
Willemsen ACH; Kok A; van Kuijk SMJ; Baijens LWJ; de Bree R; Devriese LA; Hoebers FJP; Lalisang RI; Schols AMWJ; Terhaard CHJ; Hoeben A
Clin Nutr; 2020 Aug; 39(8):2600-2608. PubMed ID: 31839429
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic antibiotics reduce hospitalisations and cost in locally advanced head and neck cancer patients treated with chemoradiotherapy: A randomised phase 2 study.
Ham JC; Driessen CM; Hendriks MP; Fiets E; Kreike B; Hoeben A; Slingerland M; van Opstal CC; Kullberg BJ; Jonker MA; Adang EM; Kaanders JH; van der Graaf WT; van Herpen CM
Eur J Cancer; 2019 May; 113():32-40. PubMed ID: 30965213
[TBL] [Abstract][Full Text] [Related]
20. Aspiration pneumonia in patients treated with radiotherapy for head and neck cancer.
Mortensen HR; Jensen K; Grau C
Acta Oncol; 2013 Feb; 52(2):270-6. PubMed ID: 23173758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
